1-3 of 3
Kazuaki Yokoyama
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Flow cytometric profiles with CD7 and CADM1 in CD4 + T cells are promising indicators for prognosis of aggressive ATL

Clinical Trials & Observations
Koji Jimbo, Toyotaka Kawamata, Yoshihiro Inamoto, Ayumu Ito, Kazuaki Yokoyama, Aki Sato, Takahiro Fukuda, Kaoru Uchimaru, Yasuhito Nannya
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3760–3770.
https://doi.org/10.1182/bloodadvances.2024013089
Published: 2024
Includes: Supplemental data
Journal Articles

The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models

Yousef Salama, Andries Hendrik Heida, Kazuaki Yokoyama, Satoshi Takahashi, Koichi Hattori, Beate Heissig
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1021–1037.
https://doi.org/10.1182/bloodadvances.2019001002
Published: 2020
Includes: Supplemental data
Journal Articles

Cell-lineage level–targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes

Kazuaki Yokoyama, Eigo Shimizu, Nozomi Yokoyama, Sousuke Nakamura, Rika Kasajima, Miho Ogawa, Tomomi Takei, Mika Ito, Asako Kobayashi, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Arinobu Tojo
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2513–2521.
https://doi.org/10.1182/bloodadvances.2017010744
Published: 2018
Includes: Supplemental data